Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia

Tamar Tadmor; Ohad Benjamini; Andrei Braester; Galia Rahav; Lior Rokach

doi:10.1038/s41375-021-01380-5

Related publications

Article2021

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Ohad Benjamini, Lior Rokach, Gilad Itchaki, Andrei Braester, Lev Shvidel, Neta Goldschmidt, Shirley Shapira, Najib Dally, Abraham Avigdor, Galia Rahav, Yaniv Lustig, Shirley Shapiro Ben David, Riva Fineman, Alona Paz, Osnat Bairey, Aaron Polliack, Ilana Levy, Tamar Tadmor

Haematologica

Article2021

Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia

Gilad Itchaki, Lior Rokach, Ohad Benjamini, Osnat Bairey, Adi D. Sabag, Helly Vernitsky, Hagai Cohen, Shahar Rotem, Uri Elia, Pia Raanani, Erez Bar‐Haim, Tamar Tadmor

Blood

Article2017

Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib

Jan A. Burger, Kelvin W. Li, Michael J. Keating, Mariela Sivina, Ahmed M. Amer, Naveen Garg, Alessandra Ferrajoli, Xuelin Huang, Hagop Kantarjian, William G. Wierda, Susan O’Brien, Marc Hellerstein, Scott Turner, Claire Emson, Shih‐Shih Chen, Xiao‐Jie Yan, Dominik Wodarz, Nicholas Chiorazzi

Article2018

Measurement of Leukemic B-Cell Growth Kinetics in Patients with Chronic Lymphocytic Leukemia

Andrea Nicola Mazzarello, Mark Fitch, Marc Hellerstein, Nicholas Chiorazzi

Letter2006

Persistence of Neointimal Growth 12 Months After Intervention and Occurrence of Delayed Restenosis in Patients With Left Main Coronary Artery Disease Treated With Drug-Eluting Stents

Marco Valgimigli, Patrizia Malagutti, Carlos A.G. van Mieghem, Sophia Vaina, Jürgen Ligthart, George Sianos, Patrick W. Serruys

Journal of the American College of Cardiology